Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-25 @ 2:31 AM
NCT ID:
NCT04446234
Eligibility Criteria:
Inclusion Criteria:
* Phase one:Effects of different types of atypical antipsychotics on cardiac safety.
1. Meet the diagnostic of "schizophrenia" according to DSM-IV and fail to take medication in the first episode or stop taking medication for more than 2 weeks
2. Han ethnic, 18-45 years old;
3. Exclude persons with mental disorders caused by organic diseases, drugs or alcohol, and other mental disorders, and serious suicide attempts.
4. Willing to participate in the trial and receive treatment;
5. Course of disease within 2 years;
6. Able to communicate effectively with the researcher and complete the written informed consent signed by hand.
Phase two:Construction of cardiac safety monitoring model
1. Meet the diagnostic of "schizophrenia" according to DSM-IV and fail to take medication in the first episode or stop taking medication for more than 2 weeks
2. Han ethnic, 18-45 years old;
3. Exclude persons with mental disorders caused by organic diseases, drugs or alcohol, and other mental disorders, and serious suicide attempts.
4. Willing to participate in the trial and receive treatment;
5. Serious arrhythmia, myocarditis, cardiomyopathy and cardiac insufficiency during taking medicine;
6. Able to communicate effectively with the researcher and complete the written informed consent signed by hand.
Exclusion Criteria:
* (1) Participating in other clinical studies; (2) Combination of DSM-IV diagnoses other than schizophrenia; (3) History of heart disease; (4) History of drug abuse in the previous 6 months; (5) Pregnant or in the first three months of lactation; (6) Combination of antipsychotics, mood stabilizers and antidepressants was used in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT04446234
Study Brief:
Protocol Section:
NCT04446234